These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 24781005)

  • 1. Analytical issues possibly affecting the performance of commercial human cytomegalovirus IgG avidity assays.
    Berth M; Grangeot-Keros L; Heskia F; Dugua JM; Vauloup-Fellous C
    Eur J Clin Microbiol Infect Dis; 2014 Sep; 33(9):1579-84. PubMed ID: 24781005
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Re-evaluation of the VIDAS(®) cytomegalovirus (CMV) IgG avidity assay: determination of new cut-off values based on the study of kinetics of CMV-IgG maturation.
    Vauloup-Fellous C; Berth M; Heskia F; Dugua JM; Grangeot-Keros L
    J Clin Virol; 2013 Feb; 56(2):118-23. PubMed ID: 23182774
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the new architect cytomegalovirus immunoglobulin M (IgM), IgG, and IgG avidity assays.
    Lagrou K; Bodeus M; Van Ranst M; Goubau P
    J Clin Microbiol; 2009 Jun; 47(6):1695-9. PubMed ID: 19339470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The combination of specific IgM antibodies and IgG antibodies of low avidity does not always indicate primary infection with cytomegalovirus.
    Lumley S; Patel M; Griffiths PD
    J Med Virol; 2014 May; 86(5):834-7. PubMed ID: 24395084
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of fully automated determination of marker-specific immunoglobulin G (IgG) avidity based on the avidity competition assay format: application for Abbott Architect cytomegalovirus and Toxo IgG Avidity assays.
    Curdt I; Praast G; Sickinger E; Schultess J; Herold I; Braun HB; Bernhardt S; Maine GT; Smith DD; Hsu S; Christ HM; Pucci D; Hausmann M; Herzogenrath J
    J Clin Microbiol; 2009 Mar; 47(3):603-13. PubMed ID: 19129411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improvement of cytomegalovirus avidity testing by adjusting the concentration of CMV-specific IgG in test samples.
    Dangel V; Bäder U; Enders G
    J Clin Virol; 2006 Mar; 35(3):303-9. PubMed ID: 16298547
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential impact of different cytomegalovirus (CMV) IgM assays on an algorithm requiring IgM reactivity as a criterion for measuring CMV IgG avidity.
    Prince HE; Lapé-Nixon M; Brenner A; Pitstick N; Couturier MR
    Clin Vaccine Immunol; 2014 Jun; 21(6):813-6. PubMed ID: 24671558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Performance of a cytomegalovirus IgG enzyme immunoassay kit modified to measure avidity.
    Prince HE; Lapé-Nixon M; Novak-Weekley SM
    Clin Vaccine Immunol; 2014 Jun; 21(6):808-12. PubMed ID: 24671557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. National prevalence estimates for cytomegalovirus IgM and IgG avidity and association between high IgM antibody titer and low IgG avidity.
    Dollard SC; Staras SA; Amin MM; Schmid DS; Cannon MJ
    Clin Vaccine Immunol; 2011 Nov; 18(11):1895-9. PubMed ID: 21918114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the Abbott AxSYM cytomegalovirus (CMV) immunoglobulin M (IgM) assay in conjunction with other CMV IgM tests and a CMV IgG avidity assay.
    Lazzarotto T; Galli C; Pulvirenti R; Rescaldani R; Vezzo R; La Gioia A; Martinelli C; La Rocca S; Agresti G; Grillner L; Nordin M; van Ranst M; Combs B; Maine GT; Landini MP
    Clin Diagn Lab Immunol; 2001 Jan; 8(1):196-8. PubMed ID: 11139220
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the indirect and IgM-capture anti-human cytomegalovirus IgM ELISA methods as confirmed by cytomegalovirus IgG avidity.
    Ikuta K; Koshizuka T; Kanno R; Inoue N; Kubo T; Koyano S; Suzutani T
    Microbiol Immunol; 2019 May; 63(5):172-178. PubMed ID: 31012489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improving diagnosis of primary cytomegalovirus infection in pregnant women using immunoblots.
    Rajasekariah H; Scott G; Robertson PW; Rawlinson WD
    J Med Virol; 2013 Feb; 85(2):315-9. PubMed ID: 23171986
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validation of an in-house assay for cytomegalovirus immunoglobulin G (CMV IgG) avidity and relationship of avidity to CMV IgM levels.
    Prince HE; Leber AL
    Clin Diagn Lab Immunol; 2002 Jul; 9(4):824-7. PubMed ID: 12093680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical evaluation of the new Roche platform of serological and molecular cytomegalovirus-specific assays in the diagnosis and prognosis of congenital cytomegalovirus infection.
    Chiereghin A; Pavia C; Gabrielli L; Piccirilli G; Squarzoni D; Turello G; Gibertoni D; Simonazzi G; Capretti MG; Lanari M; Lazzarotto T
    J Virol Methods; 2017 Oct; 248():250-254. PubMed ID: 28801056
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the LIAISON(®) CMV IgG Avidity II and the VIDAS(®) CMV IgG Avidity II assays for the diagnosis of primary infection in pregnant women.
    Sellier Y; Guilleminot T; Ville Y; Leruez-Ville M
    J Clin Virol; 2015 Nov; 72():46-8. PubMed ID: 26397203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microsphere-Based IgM and IgG Avidity Assays for Human Parvovirus B19, Human Cytomegalovirus, and Toxoplasma gondii.
    Wang Y; Hedman L; Nurmi V; Ziemele I; Perdomo MF; Söderlund-Venermo M; Hedman K
    mSphere; 2020 Mar; 5(2):. PubMed ID: 32188754
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multicenter evaluation of a rapid and convenient method for determination of cytomegalovirus immunoglobulin G avidity.
    Baccard-Longere M; Freymuth F; Cointe D; Seigneurin JM; Grangeot-Keros L
    Clin Diagn Lab Immunol; 2001 Mar; 8(2):429-31. PubMed ID: 11238233
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of two serological screening strategies for cytomegalovirus primary infection in the first trimester of pregnancy.
    Fourgeaud J; Nguyen CÂ; Guilleminot T; Ville Y; Leruez-Ville M
    J Clin Virol; 2023 Dec; 169():105614. PubMed ID: 37982548
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The value of CMV IgG avidity and immunoblot for timing the onset of primary CMV infection in pregnancy.
    Enders G; Daiminger A; Bäder U; Exler S; Schimpf Y; Enders M
    J Clin Virol; 2013 Feb; 56(2):102-7. PubMed ID: 23153820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of cytomegalovirus (CMV) IgG avidity testing in diagnosing primary CMV infection during pregnancy.
    Prince HE; Lapé-Nixon M
    Clin Vaccine Immunol; 2014 Oct; 21(10):1377-84. PubMed ID: 25165026
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.